Monday, June 3, 2013

July 3/Web: Best Practices in Prior Art Searching in Biotechnology

Examine the tools that maximize search efforts and walk-through successful processes on extracting relevant data from search results
Search Strategies Examined:
  • Searching devices, protocols and products related to biotechnology
  • Sequence searching review
  • Preparing sequence listings
Topics Covered:
  • Search Types: What kinds of prior art searches are there?
  • Search Strategies: A guide to conducting a good search.
  • Databases: Patent vs. non-patent, free vs. subscription, as well as which databases specialize in particular subject areas, along with their pros, cons & features.
Title:
Best Practices in Prior Art Searching in Biotechnology
When/Where:
July 3, 2013
12:00 PM EDT
Webinar
Speakers:
Feroze Ali & Jeffrey Sobek: Coming from varied technical and management backgrounds, they also bring a wealth of knowledge from more than 40 years of combined experience working with IP professionals from top IP and AmLaw firms to individual inventors.
By:
Legal Advantage has conducted over 3,000 combined searches, with a cross section of experience of searching for patent and non-patent literature in databases mirrored with extensive on-site search experience at the USPTO.
Credit:
AK, CA, CO, DE, FL, IA, ID, ME, MO, MS, MT, NC, ND, NM, NV, OH, OK, SC, UT, VA, VT, WA, WI, WV, WY.
More:
http://legaladvantage.net/CLE/Biotechnology.aspx



Subscribe to 4freeCLE - the Free Newsletter of Free Continuing Legal Education!
4freeCLE is the free Newsletter of free Continuing Legal Education.
Every week, it brings to your email box more than 20 opportunities to learn about the legal profession while earning Continuing Legal Education credits.
  • Webcasts: bring CLE to your home or office
  • On-Demand: let you learn what you need when you need it
  • In-Person Programs: traditional classroom settings give you the maximum opportunity for interaction and networking.
4freeCLE is and always will be free. Subscribe Now!

No comments:

Post a Comment